SLC2A5 and breast carcinoma: SLC2A5 expression is higher in metastatic liver lesions than in normal liver; and elevated in primary lung tumors; as well as in brain, colon, testis, and uterine cancers, including breast carcinoma cell lines (Uldry & Thorens, 2004).